Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:547938rdf:typepubmed:Citationlld:pubmed
pubmed-article:547938lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:547938lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:547938lifeskim:mentionsumls-concept:C0040373lld:lifeskim
pubmed-article:547938lifeskim:mentionsumls-concept:C0700292lld:lifeskim
pubmed-article:547938lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:547938pubmed:issue10lld:pubmed
pubmed-article:547938pubmed:dateCreated1980-8-25lld:pubmed
pubmed-article:547938pubmed:abstractTextPersiting pulmonary arterial hypertension, whether secondary to known lung disease or apparently idiopathic, may induce refractory hypoxaemia in the newborn. Tolazoline, pulmonary vasodilator of choice here, was used to treat this syndrome in 13 newborns. Therapeutic indications, precautions and possible side-effects are discussed.lld:pubmed
pubmed-article:547938pubmed:languagefrelld:pubmed
pubmed-article:547938pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:547938pubmed:citationSubsetIMlld:pubmed
pubmed-article:547938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:547938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:547938pubmed:statusMEDLINElld:pubmed
pubmed-article:547938pubmed:monthDeclld:pubmed
pubmed-article:547938pubmed:issn0003-9764lld:pubmed
pubmed-article:547938pubmed:authorpubmed-author:BonteJ BJBlld:pubmed
pubmed-article:547938pubmed:authorpubmed-author:VeneziaRRlld:pubmed
pubmed-article:547938pubmed:authorpubmed-author:LaloumDDlld:pubmed
pubmed-article:547938pubmed:authorpubmed-author:KobilinskyGGlld:pubmed
pubmed-article:547938pubmed:issnTypePrintlld:pubmed
pubmed-article:547938pubmed:volume36lld:pubmed
pubmed-article:547938pubmed:ownerNLMlld:pubmed
pubmed-article:547938pubmed:authorsCompleteYlld:pubmed
pubmed-article:547938pubmed:pagination981-91lld:pubmed
pubmed-article:547938pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-H...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-L...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-O...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-A...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-I...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-F...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-M...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-H...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-T...lld:pubmed
pubmed-article:547938pubmed:meshHeadingpubmed-meshheading:547938-I...lld:pubmed
pubmed-article:547938pubmed:year1979lld:pubmed
pubmed-article:547938pubmed:articleTitle[Refractory hypoxemia in the newborn. Treatment with tolazoline].lld:pubmed
pubmed-article:547938pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:547938pubmed:publicationTypeEnglish Abstractlld:pubmed